Meglumine iotroxate is a Medicine belongs to Radio graphic Contrast medium group whose information about Brand can be referenced from   Book : Martindale    Page : 1593   Edition : 38,

  ►   Brandname : Biliscopin

  ►  Strength : Solution with 10.5  %, Solution with 22.8  %,

Reference of this Medicine for its Strength can be taken from   Book : Martindale    Page : 1593   Edition : 38,
A Route of administration in pharmacology and toxicology is the path by which a drug, fluid, poison, or other substance is taken into the body. Routes of administration are generally classified by the location at which the substance is applied. Common examples include oral and intravenous administration.

  ►  Route of administration : IV infusion,
Reference :-   Book : Martindale    Page : 1593   Edition : 38,

Dosing of Medicine differ in Adult & Pediatrics ↓


Adult Dose

S.No Ailment   Route   Dose Min   Dose Max   Unit   Dosage Form   Frequency   Additional Info
1 Cholecystography IV infusion 10.5 gm Injection Over At least 30 minutes. Alternatively, a solution containing 22.8% of meglumine iotroxate may be used.
2 Cholangiography IV infusion 10.5 gm Injection Over At least 30 minutes. Alternatively, a solution containing 22.8% of meglumine iotroxate may be used.

Ref :-  Book : Martindale    Page : 1593   Edition : 38,




Pediatric Dose

S.No Ailment   Age Min   Age Max   Weight ( Kg ) Route   Dose Min   Dose Max   Unit   Dosage Form   Frequency  Additional Info  

Ref :- Book :
►  Side Effect : Anaphylactoid reactions, flushing, sensation of heat, pain at the injection site, nausea, extravasation may lead to tissue damage or thrombophlebitis., vomiting, headache, Dizziness, Urticaria, pruritus, pallor, sweating, metallic taste, weakness, coughing, rhinitis, sneezing, lachrymation, visual disturbances, Cardiovascular effects include hypotension, tachycardia, bradycardia, transient ECG abnormalities, and haemodynamic disturbances. , More severe anaphylactoid reactions lead to dyspnoea, bronchospasm, angioedema, severe urticaria, and eventually to profound hypotension, pulmonary oedema, respiratory arrest, ventricular fibrillation, circulatory failure, and cardiac arrest, fatalities, convulsion, paresthesia, Paralysis, coma, Acute renal failure, thromboembolism, Disseminated intravascular coagulation and thrombocytopenia, hyperthyroidism, thyroid storm may be precipitated in patients with thyrotoxicosis., Mild diarrhoea,
Ref :-   Book : Martindale    Page : 1593,1582   Edition : 38,

►  Drug Interaction : Drug interaction of Meglumine iotroxate is with NA

  ►    Mechanism of Drug Drug Interaction :  NA


►  Contraindication : Patient with a previous reaction to contrast media or iodine., Severe hepatic and renal impairment, severe hypertension, diabetics with renal impairment, and others who may be at increased risk of renal failure., advanced cardiac disease, phaeochromocytoma, sickle-cell disease, or hyperthyroidism or epilepsy, and in debilitated, severely ill, very old, or very young patients., hysterosalpingography in the presence of infection or inflammation of the pelvic cavity, nor during menstruation or in pregnancy.,
Ref :-   Book : Martindale    Page : 1593,1583   Edition : 38,
  ►  Mechanism of Action :   NA

Pathway of Dietry Product


​   ► Act.Comp / Nutrient / Food / Herb as follows :- NA


Dietry Substance Interactions


​   ► This Medicine interact with :- NA



ContraIndication Dietry Substance


​   ► This Medicine contraindicate with :- NA

►   Route of Elimination :   Biliary, Renal, Hepatic (Metabolism),
Ref :-   Book : Martindale    Page : 1593   Edition : 38,


►    Plasma Half-life :
  Min value :-   NA    Max value :-   NA


►    Peak Plasma Concentration :   Min value :-   NA    Max value :-   NA